Next, we investigated whether the decrease of CD3+ T cells in PD patients results from changes in the abundance of the T-cell subpopulations CD3+CD4+ or CD3+CD8+ T cells, and whether the abundance of these cell types also associates with clinical parameters of the disease. The gene discussed is CD4; the disease is Parkinson disease.